164083-26-5

Basic information

• Product Name: Carbamic acid, [3-methoxy-2-(2-oxopropyl)phenyl]-, 1,1-dimethylethyl ester
• CAS NO: 164083-26-5
• Molecular Formula: C15H21NO4
• Molecular Weight: 279.336
• Mol File: 164083-26-5.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [3-methoxy-2-(2-oxopropyl)phenyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [3-methoxy-2-(2-oxopropyl)phenyl]-, 1,1-dimethylethyl ester(164083-26-5)
• EPA Substance Registry System: Carbamic acid, [3-methoxy-2-(2-oxopropyl)phenyl]-, 1,1-dimethylethyl ester(164083-26-5)

Safety Data

• Hazardous Substances Data: 164083-26-5(Hazardous Substances Data)

Upstream product

• 598-30-1 sec.-butyllithium 
• 78191-00-1 N-Methoxy-N-methylacetamide 
• 164082-77-3 tert-butyl (3-methoxy-2-methylphenyl)carbamate 
• 172733-39-0 formyl N-methoxy-N-methylformamide 
• 19500-02-8 2-methyl-3-methoxyaniline 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 164083-57-2 1-([1,1'-biphenyl]-2-ylmethyl)-4-methoxy-2-methyl-1H-indole-3-acetamide 
• 185063-78-9 2-[1-(3-Chloro-benzyl)-4-methoxy-2-methyl-1H-indol-3-yl]-acetamide 
• 164084-54-2 4-methoxy-2-methyl-1-(phenylmethyl)-1H-indole-3-acetamide 
• 164083-55-0 1-([1,1'-biphenyl]-2-ylmethyl)-4-methoxy-2-methyl-1H-indole-3-acetic acid ethyl ester 
• 164083-56-1 1-([1,1'-biphenyl]-2-ylmethyl)-4-methoxy-2-methyl-1H-indole-3-acetic acid hydrazide 
• 185063-93-8 [1-(3-Chloro-benzyl)-4-methoxy-2-methyl-1H-indol-3-yl]-acetic acid ethyl ester 
• 185063-74-5 [1-(3-Chloro-benzyl)-4-methoxy-2-methyl-1H-indol-3-yl]-acetic acid hydrazide 
• 164083-28-7 4-methoxy-2-methyl-1-(phenylmethyl)-1H-indole-3-acetic acid ethyl ester 
• 164083-29-8 4-methoxy-2-methyl-1-(phenylmethyl)-1H-indole-3-acetic acid hydrazide 
• 17897-50-6 4-methoxy-2-methylindole 

Relevant articles and documents

AZAINDOLE COMPOUNDS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS

Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject.

PHOSPHOLIPASE INHIBITORS, INCLUDING MULTI-VALENT PHOSPHOLIPASE INHIBITORS, AND USE THEREOF, INCLUDING AS LUMEN-LOCALIZED PHOSPHOLIPASE INHIBITORS

The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a non-absorbed and/or effluxed phospholipase A2 inhibitor that is localized in a gastrointestinal lumen.

Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors

Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject.